Literature DB >> 27841674

Correlates of Bacterial Vaginosis Over Long-Term Follow-Up: Impact of HIV Infection.

Leslie S Massad1, Charlesnika T Evans2, Raymond Kang3, Anna Hotton4, Ruth Greenblatt5,6,7, Howard Minkoff8, Kerry Murphy9, Christine Colie10, Kathleen M Weber11.   

Abstract

Correlates of bacterial vaginosis (BV) are poorly understood, especially in HIV infection. In a cohort study, HIV-seropositive and comparison seronegative women were assessed every 6 months during 1994-2015. BV was considered present when three of four Amsel criteria were met. Behavioral characteristics were assessed using structured interviews. Multivariable logistic regression used generalized estimating equation models to determine factors associated with BV. Cumulative incidence of BV over time was assessed using the log-rank test. Among 3,730 women (964 HIV seronegative and 2,766 HIV seropositive) contributing 70,970 visits, BV was diagnosed at 2,586 (14.0%) visits by HIV-seronegative women and 6,224 (11.9%) visits by HIV-seropositive women (p < .0001). The cumulative incidence of BV was 530/964 (55.0%) in HIV-seronegative women and 1,287/2,766 (46.5%) in seropositive women (p < .0001). In adjusted analyses, factors associated with BV were younger age, ethnicity, lower income, less education, recruitment site, recruitment in the 2001-2002 cohort, heavier drinking, current smoking, depression, and sex with a male partner; both hormonal contraception and menopause were negatively associated with BV. Of 533 women with prevalent BV, 228 (42.8%) recurred within a year, while persistent BV was found in 12.8% of participants; neither proportion differed by HIV serostatus. Time trends in the proportion of women with BV at any single visit were not identified. BV is common among women with and at risk for HIV, but HIV infection does not predispose to BV, which is associated instead with behavioral and cultural factors.

Entities:  

Keywords:  Amsel criteria; HIV in women; bacterial vaginosis

Mesh:

Year:  2016        PMID: 27841674      PMCID: PMC5439437          DOI: 10.1089/AID.2016.0213

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  17 in total

Review 1.  The Women's Interagency HIV Study: an observational cohort brings clinical sciences to the bench.

Authors:  Melanie C Bacon; Viktor von Wyl; Christine Alden; Gerald Sharp; Esther Robison; Nancy Hessol; Stephen Gange; Yvonne Barranday; Susan Holman; Kathleen Weber; Mary A Young
Journal:  Clin Diagn Lab Immunol       Date:  2005-09

Review 2.  Sexual risk factors and bacterial vaginosis: a systematic review and meta-analysis.

Authors:  Katherine A Fethers; Christopher K Fairley; Jane S Hocking; Lyle C Gurrin; Catriona S Bradshaw
Journal:  Clin Infect Dis       Date:  2008-12-01       Impact factor: 9.079

3.  Utility of Amsel criteria, Nugent score, and quantitative PCR for Gardnerella vaginalis, Mycoplasma hominis, and Lactobacillus spp. for diagnosis of bacterial vaginosis in human immunodeficiency virus-infected women.

Authors:  Beverly E Sha; Hua Y Chen; Qiong J Wang; M Reza Zariffard; Mardge H Cohen; Gregory T Spear
Journal:  J Clin Microbiol       Date:  2005-09       Impact factor: 5.948

4.  Longitudinal analysis of bacterial vaginosis: findings from the HIV epidemiology research study.

Authors:  D J Jamieson; A Duerr; R S Klein; P Paramsothy; W Brown; S Cu-Uvin; A Rompalo; J Sobel
Journal:  Obstet Gynecol       Date:  2001-10       Impact factor: 7.661

5.  The occurrence of vaginal infections among HIV-infected and high-risk HIV-uninfected women: longitudinal findings of the women's interagency HIV study.

Authors:  D Heather Watts; Gayle Springer; Howard Minkoff; Sharon L Hillier; Lisa Jacobson; Michael Moxley; Jessica Justman; Helen Cejtin; Casey O'Connell; Ruth M Greenblatt
Journal:  J Acquir Immune Defic Syndr       Date:  2006-10-01       Impact factor: 3.731

6.  Lower genital tract infections among HIV-infected and high-risk uninfected women: findings of the Women's Interagency HIV Study (WIHS).

Authors:  R M Greenblatt; P Bacchetti; S Barkan; M Augenbraun; S Silver; R Delapenha; P Garcia; U Mathur; P Miotti; D Burns
Journal:  Sex Transm Dis       Date:  1999-03       Impact factor: 2.830

7.  Home Screening for Bacterial Vaginosis to Prevent Sexually Transmitted Diseases.

Authors:  Jane R Schwebke; Jeannette Y Lee; Shelly Lensing; Susan S Philip; Harold C Wiesenfeld; Arlene C Seña; Nikole Trainor; Nincoshka Acevado; Lisa Saylor; Ann M Rompalo; Robert L Cook
Journal:  Clin Infect Dis       Date:  2015-11-26       Impact factor: 9.079

8.  Bacterial vaginosis (BV) candidate bacteria: associations with BV and behavioural practices in sexually-experienced and inexperienced women.

Authors:  Katherine Fethers; Jimmy Twin; Christopher K Fairley; Freya J I Fowkes; Suzanne M Garland; Glenda Fehler; Anna M Morton; Jane S Hocking; Sepehr N Tabrizi; Catriona S Bradshaw
Journal:  PLoS One       Date:  2012-02-17       Impact factor: 3.240

9.  Women's Management of Recurrent Bacterial Vaginosis and Experiences of Clinical Care: A Qualitative Study.

Authors:  Jade Bilardi; Sandra Walker; Ruth McNair; Julie Mooney-Somers; Meredith Temple-Smith; Clare Bellhouse; Christopher Fairley; Marcus Chen; Catriona Bradshaw
Journal:  PLoS One       Date:  2016-03-24       Impact factor: 3.240

10.  Supplementation of standard antibiotic therapy with oral probiotics for bacterial vaginosis and aerobic vaginitis: a randomised, double-blind, placebo-controlled trial.

Authors:  Piotr B Heczko; Anna Tomusiak; Paweł Adamski; Artur J Jakimiuk; Grzegorz Stefański; Aleksandra Mikołajczyk-Cichońska; Magdalena Suda-Szczurek; Magdalena Strus
Journal:  BMC Womens Health       Date:  2015-12-03       Impact factor: 2.809

View more
  3 in total

1.  Trends in Bacterial Vaginosis Prevalence in a Cohort of U.S. Women with and at Risk for HIV.

Authors:  L Stewart Massad; Elizabeth M Daubert; Charlesnika T Evans; Howard Minkoff; Seble Kassaye; Jodie Dionne-Odom; Dominika Seidman; Kerry Murphy; Maria L Alcaide; Adaora A Adimora; Anandi N Sheth; Elizabeth T Golub; Audrey L French; Kathleen M Weber
Journal:  J Womens Health (Larchmt)       Date:  2021-08-27       Impact factor: 3.017

2.  Prevalence and predictors of bacterial vaginosis in HIV-infected women in Maharashtra, India.

Authors:  S Joshi; A Mane; R Muwonge; U Divate; V Padbidri; V Kulkarni; R Gangakhedkar; R Sankaranarayanan
Journal:  Int J STD AIDS       Date:  2020-03-31       Impact factor: 1.359

3.  Obesity is associated with lower bacterial vaginosis prevalence in menopausal but not pre-menopausal women in a retrospective analysis of the Women's Interagency HIV Study.

Authors:  Elizabeth Daubert; Kathleen M Weber; Audrey L French; Dominika Seidman; Katherine Michel; Deborah Gustafson; Kerry Murphy; Christina A Muzny; Maria Alcaide; Anandi Sheth; Adaora A Adimora; Gregory T Spear
Journal:  PLoS One       Date:  2021-03-08       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.